| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33b011e77b33662b8bf1f2ff2de7b661 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 |
| filingDate |
2019-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f39e9e6d0ff53046d5d65b0f9bba6cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07598cd01cc21ca684f0abfadd2ff1d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e89c771e5957720ccce0a21f9fa8f8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b461d29ce388ea314804a638962e7307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84e9fe3e972230e593433ce53f0ab35e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a154f0601c31210a511e28f911ef5977 |
| publicationDate |
2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020023096-A1 |
| titleOfInvention |
Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use |
| abstract |
A hemostatic composition is provided. The hemostatic composition includes a hemostatically effective amount of a hemostatic agent that includes a nanoparticle and a polyphosphate polymer attached to the nanoparticle. Also provided are medical devices and methods of use to promote blood clotting. |
| priorityDate |
2013-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |